Pharmaron Beijing Co., Ltd.
300759
Classificação em ações
#2352
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Preço da ação
$5.58
Valor de mercado
$8.24B
Variação (1 dia)
-3.77%
Variação (1 ano)
28.36%
País
CN
Negociar Pharmaron Beijing Co., Ltd. (300759)
Categoria
Healthcare
Receita da Pharmaron Beijing Co., Ltd. (300759)
Receita em Jun 2026 TTM: $2.28B
De acordo com os últimos relatórios financeiros da Pharmaron Beijing Co., Ltd., a receita atual da empresa (TTM) é $2.28B. Em 2024, a empresa obteve uma receita de $1.68B um aumento em relação a a receita do ano 2023, que foi de $1.63B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Pharmaron Beijing Co., Ltd. de 2014 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $2.28B | 12.93% |
| 2025 | $2.01B | 19.79% |
| 2024 | $1.68B | 3.18% |
| 2023 | $1.63B | 9.52% |
| 2022 | $1.49B | 27.08% |
| 2021 | $1.17B | 49.03% |
| 2020 | $785.83M | 45.64% |
| 2019 | $539.57M | 27.62% |
| 2018 | $422.78M | 19.90% |
| 2017 | $352.61M | 49.80% |
| 2016 | $235.38M | 35.50% |
| 2015 | $173.71M | 36.12% |
| 2014 | $127.61M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $12.62B | 454.89% |
US
|
|
| $2.23B | -2.07% |
US
|
|
| $15.74B | 592.03% |
AU
|
|
| $10.11B | 344.41% |
BE
|
|
| $6.02B | 164.66% |
NL
|
